Anesthetic drugs & techniques

Anesthetic Management for Ventricular Tachycardia Ablation: A National Anesthesia Clinical Outcomes Registry Analysis

J Cardiothorac Vasc AnesthPublished Retrospective cohort study

Authors' conclusion

GA has remained the primary anesthetic type for VT ablation despite the 2019 Expert Consensus Statement on Catheter Ablation of Ventricular Arrhythmias suggested its avoidance in idiopathic VT.

Study context

Population
Adults (≥18 years) undergoing elective ventricular tachycardia (VT) ablation, 2013–2021, National Anesthesia Clinical Outcomes Registry
Participants
15,505 adults
Exposure
Monitored anesthesia care (MAC) vs general anesthesia (GA) for VT ablation, before vs after the 2019 Expert Consensus Statement
  • GAn = 9,790
Outcome
Anesthetic type for VT ablation
Methodological detailsregistry analysis, interrupted time-series analysis, multivariate analysis
  • Registry analysis
  • Interrupted time-series analysis
  • Multivariate analysis

Main finding

As reported in the abstract

GA

63.1%

9,790

Observational data: associations, not effects.

Further findings

OutcomeEstimateP value
Change in MAC use after 2019 consensus statement (interrupted time series)Post-consensus statementaOR (immediate change in intercept) 1.41P = 0.1629
Change in MAC use after 2019 consensus statement (interrupted time series)Post-consensus statementaOR (change in slope) 1.06 per quarterP = 0.1591

Change in MAC use after 2019 consensus statement (interrupted time series)

No statistically significant increase in MAC

Factors associated with anesthetic approach (multivariate)

Sex, ASA physical status, age and geographic location significantly associated with anesthetic approach

Original publication

Anesthetic Management for Ventricular Tachycardia Ablation: A National Anesthesia Clinical Outcomes Registry Analysis. J Cardiothorac Vasc Anesth. Published 16 December 2023. doi:10.1053/j.jvca.2023.12.021

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.